These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2482551)

  • 21. Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.
    Celis E; Karr RW
    J Virol; 1989 Feb; 63(2):747-52. PubMed ID: 2463381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of amino acids in HLA-DPw4b beta and -DR5 beta 1 chains that are involved in antibody binding epitopes using site-directed mutagenesis and DNA-mediated gene transfer.
    Yu WY; Watts R; Karr RW
    Hum Immunol; 1990 Feb; 27(2):122-35. PubMed ID: 1688836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.
    Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S
    J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope mapping of an HLA-DR-specific monoclonal antibody produced by using human-mouse transfectant cells.
    Madrigal JA; Ikeda H; Marsh SG; Heyes JM; Kennedy LJ; Trowsdale J; Bodmer JG
    J Immunol; 1989 Dec; 143(12):4084-9. PubMed ID: 2480386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules.
    Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL
    Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new monoclonal antibody recognizing a linear determinant on the HLA-DRalpha chain N-terminus.
    Ting YT; Temme S; Koch N; McLellan AD
    Hybridoma (Larchmt); 2009 Dec; 28(6):423-9. PubMed ID: 20025501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for heterogeneity of the DPA and DPB alleles derived from a DRw11,DQw7,DPw4 cell line.
    Woulfe SL; Rice K; Didier DK; Harris MR; Schiffenbauer J; Klearman M; Farrar MA; Schwartz BD
    Hum Immunol; 1989 Sep; 26(1):39-45. PubMed ID: 2777643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple regions of HLA-DR beta 1 chains determine polymorphic epitopes recognized by monoclonal antibodies.
    Alber CA; Watts R; Klohe EP; Drover S; Marshall WH; Radka SF; Karr RW
    J Immunol; 1989 Oct; 143(7):2248-55. PubMed ID: 2476501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding.
    Díaz G; Amicosante M; Jaraquemada D; Butler RH; Guillén MV; Sánchez M; Nombela C; Arroyo J
    Int Immunol; 2003 May; 15(5):565-76. PubMed ID: 12697658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization by high resolution isoelectric focusing of the products encoded by the class II region loci of the MHC in humans. II. DP alpha and DP beta gene variants.
    Rodriguez de Cordoba S; Marshall P; Rubinstein P
    J Immunol; 1989 Feb; 142(3):836-41. PubMed ID: 2492330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DP typing by analysis of DNA restriction fragment length polymorphisms in the HLA-DP beta subregion.
    Maeda M; Inoko H; Ando A; Uryu N; Nagata Y; Tsuji K
    Hum Immunol; 1988 Apr; 21(4):239-48. PubMed ID: 2897348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A "new" supertypic HLA-DP related determinant detected by primed lymphocyte typing (PLT).
    Odum N; Hofmann B; Hyldig-Nielsen JJ; Jakobsen BK; Morling N; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1987 Feb; 29(2):101-9. PubMed ID: 2440144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of monoclonal antibodies directed against HLA class II molecules.
    Cabrera T; Ruiz-Cabello F; Lopez MA; de la Higuera B; Sanchez M; Garrido F
    Hybridoma; 1986; 5(3):191-7. PubMed ID: 3770773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical role of HLA-DR beta 1 residue 58 in multiple polymorphic epitopes recognized by xenogeneic and allogeneic antibodies.
    Klohe E; Pistillo MP; Ferrara GB; Goeken NE; Greazel NS; Karr RW
    Hum Immunol; 1992 Sep; 35(1):18-28. PubMed ID: 1282512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterization of an HLA-DR alpha-specific monoclonal antibody using L-cell transfectants expressing human and mouse class II major histocompatibility dimers.
    Palmer D; Kevany M; Mackworth-Young C; Batchelor R; Lombardi G; Lechler R
    Immunogenetics; 1991; 33(1):12-7. PubMed ID: 1995473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An HLA-DR/DP recombinant family involving DPw6. Evidence for cross-reactivity between DPw6 and GNN2B.
    Odum N; Hartzman R; Jakobsen BK; Morling N; Platz P; Robbins FM; Ryder LP; Shaw S; Svejgaard A
    Tissue Antigens; 1986 Jan; 27(1):44-52. PubMed ID: 3082036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of HLA-DR2, HLA-DPw4, and T cell receptor alpha chain genes on the susceptibility to multiple sclerosis.
    Sherritt MA; Oksenberg J; de Rosbo NK; Bernard CC
    Int Immunol; 1992 Feb; 4(2):177-81. PubMed ID: 1352460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of HLA-DP beta residue 69 in the definition of antibody-binding epitopes.
    Arroyo J; Alvarez AM; Nombela C; Sánchez-Pérez M
    Hum Immunol; 1995 Jul; 43(3):219-26. PubMed ID: 7558939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA antibody responses in HLA class I transgenic mice.
    Tahara T; Yang SY; Khan R; Abish S; Hämmerling GJ; Hämmerling U
    Immunogenetics; 1990; 32(5):351-60. PubMed ID: 2249882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.